Dendritic cells (DCs), including conventional DCs (cDCs) and plasmacytoid DCs (pDCs) are critical for initiating and controlling the immune response. However, study of DC, particularly pDC, function is hampered by their low frequency in lymphoid organs, and existing methods for in vitro DC generation preferentially favor the production of cDCs over pDCs. Here, we demonstrated that pDCs could be efficiently generated in vitro from common lymphoid progenitors (CLPs) using Flt3 ligand (FL) in three different culture systems, namely feeder-free, BM-feeder and AC-6-feeder. This was in stark contrast to common DC progenitors (CDPs), in which cDCs were prominently generated under the same conditions. Moreover, the efficiency and function of pDCs generated from these three systems varied. While AC-6 system showed the greatest ability to support pDC development from CLPs, BMfeeder system was able to develop pDCs with better functionality. pDCs could also be expanded in vivo using hydrodynamic gene transfer of FL, which was further enhanced by the combined treatment of FL and IFN-α. Interestingly, IFN-α selectively promoted the proliferation of CLPs and not CDPs, which might contribute to enhanced pDC development. Together, we have defined conditions for in vitro and in vivo generation of pDCs, which may be useful for investigating the biology of pDCs.
Introduction
Plasmacytoid DC (pDCs) are innate immune cells that are capable of producing large quantities of type I interferon (IFN-I) upon stimulation and activation [1, 2] . The frequencies of pDCs are low and their life span is short compared to other immune cells. Therefore, they are constantly replenished from their progenitors to maintain their homeostasis at steady state [3] . Progenitors of both myeloid and lymphoid lineages are able to generate pDCs [4, 5] . Recently, two newly identified progenitors with immunophenotypes of lin -CD11c -BST2 + IL-7Rα + and lin -c-Kit int/lo Flt3 + M-CSFR -, respectively, were reported to show a greater pDC potential [6, 7] .
In fact, we and others also showed that CLPs had the ability to generate more pDCs than cDCs [6, 8] . Nevertheless, the developmental origins of pDCs are still not completely understood.
While several cytokines, such as Flt3 ligand (FL), M-CSF, and GM-CSF have been shown to regulate pDC development, the most physiologically relevant cytokine for maintaining the homeostasis of pDCs at steady state is FL [5, 9, 10] . DCs, including pDCs, are generated from Flt3-expressing progenitors, regardless of lymphoid or myeloid lineage [11, 12] . Targeted deletion of FL or Flt3 in mice results in severely impaired production of pDCs in addition to cDCs and interstitial dermal DCs [13, 14] .
Several transcriptional factors are involved in regulation of pDC development. E2-2/Tcf4 is predominantly expressed in human and mouse pDCs. Genetic ablation of E2-2 results in reduction of pDCs but not of other lineages of DCs [15] . E2-2 directly activates multiple pDCenriched genes, including transcription factors involved in pDC development, like Spib, Irf8 and function, such as Irf7 [16, 17] . Therefore, E2-2 appears to be an essential and specific transcription factor for pDC development. Moreover, continuous expression of E2-2 is also required to maintain the lineage identity of mature pDCs. Inducible deletion of E2-2 in mature pDCs results in conversion of pDCs into cells with cDC properties, including loss of pDC markers, acquisition of dendrites, induction of cDC signature genes and increase of cDC functions [17] .
pDCs express TLR7 and TLR9 and are capable of producing large amounts of IFN-I and upregulating MHC class II and costimulatory molecules such as CD80 and CD86 in response to viral infections or TLR stimulation [18, 19] . pDC ablation using BDCA2-DTR transgenic mice reveals that pDCs are essential for early IFN-I production and influence the accumulation of viral specific NK and CD8 + T cells in a virus-dependent manner [20] . Mouse pDCs also selectively express BST2/PDCA1 and Siglec-H. A deficiency of Siglec-H in pDC results in enhanced production of IFN-I and proinflammatory cytokines in response to CpG ODN, suggesting that Siglec-H negatively regulates pDC functions [21] . Interestingly, conditional ablation of pDCs using Siglec-H-DTR transgenic mice enhances the activity of antigen specific CD4 but reduces the activity of CD8, the numbers of CD4 + FoxP3 + Treg cells and the host defense against bacterial infections in vivo, suggesting that pDCs also play roles in initiation of the adaptive immune responses [21] . Cytokines have been shown to facilitate DCs generation in vitro from a number of progenitors [22, 23] . Among them, GM-CSF and FL, respectively, are the most commonly used cytokines. While GM-CSF preferentially induces cDC formation, FL can promote the development of both cDCs and pDCs. Cotreatment of GM-CSF and FL inhibits FL-dependent pDC development while cDC generation is not affected [24] . GM-CSF selectively utilizes its signal mediator STAT5 to bind the promoter and suppress Irf8 and other pDC specific transcription factors in lin of National Taiwan University College of Medicine, Taiwan. All mice were bred and kept under specific pathogen-free conditions. Protocol and the use of the animals were reviewed and approved by the Institutional Animal Care and Use Committee of National Taiwan University College of Medicine (Permit Number: 20120075). Water and food were provided sufficiently daily and all efforts were made to minimize suffering of the animals.
Antibodies and flow cytometry
Staining was performed with hybridoma supernatant 2.4G2 Fc block (ATCC HB197) in FACS staining buffer at 4°C. The following antibodies were purchased from Biolegend: biotin-antiCD11c (N418), Brilliant Violet 650 anti-CD11c (N418), PE-anti-CD11b (M1/70), PE-anti-CD3 (17A2), PE-anti-CD8 (53-6.7), PE-anti-Gr-1 (RB6-8C5), PE-anti-CD19 (eBio1D3), PEanti-TER119 (TER-119), PE-anti-Thy1.1 (HIS51), PE-anti-NK1.1 (PK136), APC-anti-B220 (RA3-6B2), FITC anti-TLR9 (M9.D6), Brilliant Violet 421 anti-B220 (RA3-6B2), PerCPeFluor710-anti-Siglec-H (eBio440c), PerCP-eFluor710-anti-c-Kit (2B8), APC-anti-M-CSFR (AFS98), PE/Cy7-anti-IL-7Rα (A7R34), FITC-anti-Sca-1 (D7). PE-anti-MHCII (NIMR-4) and FITC-anti-MHCII (NIMR-4) were purchased from eBioscience, and FITC-anti-IFNα (RMMA-1) was purchased from PBL Assay Science. APC-Cy7-Streptavidin was used as the secondary antibody (Biolegend). Flow data were analyzed with FlowJo (FLOWJO LLC) software.
Progenitor analysis and cell sorting
BM cells following lysis of RBC were stained with PE-conjugated lineage markers, including anti-CD3, anti-CD8, anti-B220, anti-CD19, anti-CD11b, anti-Gr-1, anti-Thy1.1, anti-NK1. [28] , respectively, were sorted with BD FACSAria IIIu (BD Biosciences).
In vitro DC development
For feeder-free (FF) system, 1x10 4 CLPs were seeded in 96-well U-bottom plates supplied with 100 ng/ml of hFL-Ig (FL in short, produced in-house from an expression cell line in 
Hydrodynamic gene transfer (HGT)
HGT was done as described [8] . 
Virus infection
DCs derived from CLPs using AC-6-feeder system for 16 d were stained with anti-CD11b-PE first, followed by negative selection for pDCs using EasySep PE-selection kit (Stemcell). Typically, the purity of pDCs after negative selection was between 92-95%. Purified pDCs at 1.2x10 5 were infected with or without VSV at an MOI of 10 for 18 h. The culture supernatant were collected and subjected to ELISA for IFN-α (PBL Assay Science) as described in the following.
Quantitative RT-PCR
The mRNA of cDCs and pDCs was prepared using TurboCapture kit (QIAGEN). The cDNA was synthesized with HiScript I reverse transcriptase (BIONOVAS) and then subjected to RTqPCR using primers to Tcf4, Rag1, Id2, Ifna, Ifnb, Actb and/or Rpl7. Data were normalized to Actb. Primer sequences are in the Table 1 .
Proliferation assay
For proliferation assay, BrdU (0.8 mg/mouse, Sigma) was intraperitoneally injected into mice that were in vivo delivered with the indicated plasmids using HGT, at final 2 h before CLPs or CDPs were sorted, fixed and subjected to intracellular staining using anti-BrdU antibody (eBioscience) as described [32] . Table 1 . Primer sequences for quantitative PCR. 
Statistical analyses
All values are shown as mean ± SD. Two-tailed, unpaired Student's t test was used to assess statistical significance: Ã , P < 0.05; ÃÃ , P < 0.01; and ÃÃÃ , P < 0.005.
Results

In vitro expansion of pDCs from CLPs
We have previously shown that CLPs could preferentially develop pDC in vitro [8] . Therefore, we further investigated pDC potential of CLPs. CLPs were first sorted out from BM of WT mice (S1 Fig) , and then cultured in vitro using three different systems, namely feeder-free (FF), BM-feeder (BF) and AC-6-feeder (AC-6). In FF system, the majority of DCs developed were pDCs, while relatively few cDCs were generated (Fig 1A-1D ). Likewise, pDCs were still mainly developed in BF system (Fig 1E-1H ). We also sorted out CDPs and did in vitro culture using FF and BF systems. In contrast to CLPs, CDPs predominantly generated cDCs in FF (Fig 1J-1M ) and BF (Fig 1N-1Q M-CSFR -) with prominent pDC potential has been identified [7] . We also examined their pDC potential in FF system. Although they generated higher percentages of pDCs than did CDPs, their pDC potential was still lower than those of CLPs (S2 Fig) . These results suggest that CLPs develop more pDCs than cDCs in vitro and that they have a greater pDC potential than do CDPs and M-CSFR -DC progenitors.
Dose-dependent effect of AC-6 feeder and FL on pDC development from CLPs
We next examined AC-6 system. To titrate the effect of AC-6, 500 CLPs were cultured with increased numbers of AC-6 in the presence of 100 ng/ml FL. Interestingly, AC-6 regulated pDC developmental potential in a dose-dependent manner. While lower numbers of AC-6 (3.9x10 4 /well) promoted cDCs development, higher numbers of AC-6 (5.9x10 4 /well) supported pDCs formation, resulting in increased pDC frequency in the culture (Fig 2A-2C) . Moreover, higher numbers of AC-6 were also capable of supporting more pDC generation ( Fig  2C) . Under this condition, pDCs could be expanded as high as 100-fold. We next titrated dose effect of FL on DC development from CLPs using the optimal numbers of AC-6. Similar to the dose effect of AC-6 feeders, low-dose FL (50 ng/ml) preferentially promoted cDC development while high-dose FL (100-200 ng/ml) promoted pDC development (Fig 2D-2F) . Moreover, the morphology of the colonies of pDCs and cDCs derived from AC-6 system were distinct; with cDCs larger and more adherent and pDCs smaller, rounded-shape and non-adherent (Fig 2G) . However, the dose-dependent effect of FL on pDC development from CLPs was not observed in CDPs, as cDCs were still preferentially generated even at high-dose of FL (Fig 2H-2J) . Taken together, while all three culture systems were able to generate pDCs from CLPs, AC-6 system had the greatest ability to generate pDCs. Moreover, there is dose-dependent effect of FL or AC-6 cells on pDC development from CLPs, at least, in AC-6 culture system. In Vitro and In Vivo Generation of pDCs from CLPs Since we have shown that CLPs exhibited a greater pDC potential in three different culture systems, we further characterize the phenotypes and functions of pDCs derived from CLPs. pDCs express unique surface markers, such as Siglec-H and BST2, and are the most potent IFN-I producing cells upon stimulation. Therefore, we first examined the expressions of these two markers on the pDCs derived from these three culture systems. While FF-and BF-derived pDCs (FF-pDCs and BF-pDCs, respectively) expressed Siglec-H and BST2, AC-6-derived pDCs (AC-6-pDCs) hardly expressed either molecule (Fig 3A and 3B) . Moreover, basal levels of MHC class II on AC-6-pDCs were also lower than those on FF-pDCs or BF-pDCs (Fig 3C) . CpG ODN stimulation upregulated MHC class II and CD86 on BM pDCs or FF-and BF-pDCs ( Fig  3C and 3D) . However, the expression of MHC class II and CD86 was not induced in AC-6-pDCs in response to CpG ODN. We next examined CpG-induced IFN-I in the pDCs by intracellular staining. While BM pDCs produced significant amount of IFN-α, BF-pDCs produced relatively low amounts. However, both FF-pDCs and AC-6-pDCs failed to produce IFN-α upon stimulation (Fig 3E) . The unresponsiveness of AC-6-pDCs to CpG stimulation was not due to the lack of TLR9 expression because they appeared to express comparable levels of TLR9 compared to FF-pDCs ( S3 Fig). Nevertheless, AC-6-pDCs, like BM pDCs, expressed higher levels of Tcf4 (encodes E2-2) and Rag1, two pDC-specific factors, but lower levels of Id2, a cDC-specific factor, as compared to AC-6-cDCs and BM cDCs, respectively (Fig 4A-4C) . Since TLR9 is expressed inside endosomes, we reasoned that the unresponsivenesse of AC-6-pDCs to CpG might be due to impaired ability to engulf the ligand. Therefore, we next infected AC-6-pDCs with vesicular stomatitis virus (VSV). Infection of VSV was able to upregulate small but significant amount of CD86 on AC-6-pDCs (Fig 4D) although there was no detectable change on MHC class II expression (Fig 4E) . Moreover, VSV also induced the expression of IFN-α (Fig 4F), IFN-β (Fig 4G), IFIT1 (Fig 4H) , an IFN-stimulated gene, and the production of IFN-α protein (Fig 4I) in AC-6-pDCs. We also infected BM-derived and CLPderived pDCs from FF system with VSV and assessed the upregulation of CD86 and MHC class II and IFN-α-producing ability. Interestingly, basal and induced levels of CD86 on CLPderived pDCs and cDCs were lower than those of BM-derived pDCs and cDCs (S4 Fig C, E , J, and L). Like AC-6-pDCs, MHC class II on CLP-derived pDCs was not induced by VSV infection (Fig 4E and S4K and S4M Fig) . Moreover, CLP-derived pDCs produced significantly lower amounts of IFN-α than did BM-derived pDCs (S4 Fig G and N) . Since CLP-derived pDCs from FF system and AC-6 system (Fig 4) produced similar levels of IFN-α, these results suggest that low IFN-I-producing ability of CLP-derived pDCs is probably an intrinsic property of CLP origin and not due to AC-6 culture system. Together, these results suggest that pDCs from BM-or FF-system display more mature phenotype and higher functionality than do pDCs from AC-6 system.
IFN-I enhances FL-dependent pDC generation in vivo
We have previously demonstrated that IFN-I was capable of enhancing FL-dependent pDC production in vitro [8] . Here we delivered FL and IFN-I into mice and examined the enhancement of pDC expansion in vivo. The circulating levels of FL following hydrodynamic injection of FL-expressing plasmid rose to 2.5 μg/ml from 500 pg/ml and gradually subsided 3 d after the treatment (Fig 5A) . Likewise, the production of serum IFN-α also significantly increased, at least, for 2 d following in vivo delivery of IFN-α4-expressing plasmid (Fig 5B) . In vivo delivery of plasmid expressing FL alone increased the production of pDCs in the BM and spleen. Delivery of both FL and IFN-α4 further enhanced the percentages and numbers of pDCs (Fig 5C-5H) . The proliferation of CLPs, as indicated by BrdU incorporation, was increased in BM CLPs following FL treatment compared to EV control (Fig 6A) . Interestingly, IFN-α further enhanced FL-dependent proliferation of CLPs (Fig 6A and 6B) . Although FL also slightly increased the proliferative activity of CDPs compared to EV control, IFN-α did not show enhanced mitogenic activity on CDPs (Fig 6A and 6C) . However, a comparable proliferative activity was observed in BM Gr-1 + granulocytes following the same treatments (Fig 6A and   6D ). results suggest that there is a selective enhancement of CLP proliferation by IFN-α in vitro and in vivo. We next examined the functions of the in vivo expanded pDCs by sorting them out and stimulating them with CpG ODN. The expression of MHC class II was increased in BM pDCs of untreated or EV-treated mice in response to CpG (Fig 7A) . The upregulation of MHC class II was also observed in BM pDCs of mice treated with FL or FL plus IFN-α4. However, the upregulation of MHC class II was less obvious in the treated splenic pDCs (Fig 7B) . PDCs from mice treated with EV or FL were also able to produce significant amounts of IFN-I upon stimulation (Fig 7C and 7D) . However, co-treatment of FL and IFN-α4 impeded IFN-I-producing ability in pDCs. Together, these results suggest that although IFN-I enhances pDC production, it may have adverse effects on IFN-I-producing ability in pDCs. 
Discussion
Preferential pDC development from CLPs in vitro
While CLPs can develop both cDCs and pDCs in vitro, here we have defined the conditions to predominantly generate pDCs. Although three in vitro culture systems were able to promote pDC formation, their developmental efficiency and differentiation ability varied. Developmental efficiency, defined as the ratios of the number of pDCs generated over initial input number of CLPs, for FF and BF systems was 0.8 and 0.2 (Fig 1D and 1I) , respectively, which was less efficient. In contrast, AC-6 system was able to robustly produce pDCs, in which one CLP could generate almost 100 pDCs under optimal conditions (Fig 2C) . Differentiation ability, assessed by expression of pDC markers and responses to TLR9 ligand or virus infection, was better in FF and BF systems than in AC-6 system. It was interesting to note that AC-6-pDCs did not express Siglec-H or BST2. Their MHC class II or CD86 was not upregulated and they hardly produce IFN-I in response to CpG ODN despite that they expressed TLR9 ( S3 Fig). Nevertheless, AC-6-pDCs expressed high levels of Tcf4 and Rag1 and low levels of Id2 as opposed to AC-6-cDCs. Moreover, when AC-6-pDCs were infected with VSV, they were able to upregulate CD86 and express IFN-I and IFN-stimulated genes. One possibility for the differential response is that AC-6-pDCs may have a deficiency in CpG uptake because TLR9 is expressed in the endosomes. Viruses, on the other hand, were able to actively infect AC-6-pDCs, which permitted them to mount proper responses. Alternatively, viral infections might engage multiple pattern recognition receptors, thus triggering stronger signals that overcome the defect in AC-6-pDCs. Therefore, these results suggest that although AC-6 system has the greatest ability to support CLPs to develop pDCs, the AC-6-pDCs appeared to display only "pDC-like" phenotype due to lack of Siglec H/BST2 expression and TLR9 response. AC-6 system has been used to facilitate DC development in vitro to dissect the roles of progenitors of lymphoid and myeloid lineages [12] and to define clonogenic property of CDPs and Lin -c-Kit int/lo Flt3 + M-CSFR -, a newly identified DC progenitor [7, 28] . Moreover, we have previously used this system to reveal a role of IFN-I in FL-dependent pDC development from CLPs [8] . Therefore, it is a well-established system and it has provided invaluable information, at least, for the developmental control of DCs. Nevertheless, the functions of AC-6-DCs, particularly AC-6-pDCs, have not been characterized. Therefore, our findings have documented and raised the awareness of the inferior functionality of CLP-derived pDCs from AC-6 system. Therefore, we propose that while FF or BF system is suitable for characterization of immunophenotype and function of pDCs, AC-6 system is more appropriate for studying the homeostasis of pDCs.
Feeder-free/ BM-feeder versus AC-6-feeder system
Although the exact mechanisms for the efficient DC generation from AC-6 system remain to be determined, cobblestone area-forming cells (CAFC) developed in AC-6 system might facilitate cell proliferation [34] , which does not occur in FF or BF system. In addition to CAFC, hematopoietic cytokines secreted by the feeders and cell-cell contact between feeders and CLPs might also play a role. It is known that a stromal cell line can constitutively produce hematopoietic cytokines such as IL-7, SCF, M-CSF and FL to support hematopoiesis in vitro [35] . Moreover, heparan sulfate present on the surface of hematopoietic stromal cells has been shown to control adhesion and growth of hematopoietic stem and progenitor cells [36] . Therefore, differences in quantity or quality of these factors in FF, BF and AC-6 system may account for the distinct phenotypes. Although in vitro BM-derived pDCs using FF system are capable of secreting significant amounts of TNF/IL-6 and IFN-I in response to TLR7 or TLR9 stimulation [19, 26, 37] , we and others showed that CLP-derived pDCs using BF, but not FF system, only secreted relatively limited amount of IFN-I upon CpG stimulation [6] . Therefore, in vitro derived pDCs from different precursors may show distinct properties.
Dose-dependent effect of FL and AC-6 on DC development from CLPs
We have previous shown a dose-dependent effect of FL on DC development from CLPs [8] .
Here we further demonstrated a similar effect for AC-6 on DC generation. At low numbers of AC-6, cDCs were preferentially developed, while at high numbers pDCs were predominantly generated. These results further support the model of instructive cytokine signals for lineage commitment [9, 38] . However, this phenomenon seemed to be limited to CLPs and not to CDPs, as CDPs mainly generated cDCs at low or high doses of FL. In fact, clonal analysis of pDC potential from CDPs using FL as the sole hematopoietic cytokine also reveals that pDCrestricted clones are only 1% in this population [6] . Interestingly, CLPs, and not CMP, are also the major pDC producers when using M-CSF to drive DC development in vitro [37] . Despite that FL or M-CSF alone preferentially induce pDC formation from CLPs, it should be noted that DC-poietin like FL, M-CSF and GM-CSF most likely function in concert to regulate DC homeostasis in vivo [39] . In fact, FL can act together with M-CSF to enhance the expansion of pDC from CDPs, suggesting that CDPs still have a potential to switch the developmental program for pDC formation [28] .
Effect of IFN-I on pDC development and functions
We have previously shown that FL induces IFN-I production in CLPs, which in turn upregulates Flt3 on CLPs and promotes survival, proliferation of CLPs and their differentiation into pDCs in vitro [8] . Here we extended these findings and showed that in vivo administration of FL and IFN-I together could further enhance pDC generation compared to single treatment of FL. IFN-I has been shown to stimulate proliferation of HSC in a STAT1-and Sca-1-dependent manner [40] . Here, we also found that IFN-α selectively enhanced FL-dependent proliferation of CLPs both in vitro and in vivo, while it had no effect on CDPs or Gr-1 + granulocytes. These results suggest that differentiation process may alter intracellular signaling networks in CLPs, CDPs, and granulocytes, respectively, resulting in distinct phenotypes upon IFN-I stimulation. Interestingly, in vivo IFN-I treatment also inhibited the production of IFN-I from pDCs in response to CpG. It has been reported that TGFβ and IL-10 block CpG-or influenza virusinduced IFN-I production in splenic pDCs, with TGFβ inhibiting proximal signaling via TLR9-induced IFN-I mRNA expression and IL-10 blocking IFN-I receptor-mediated autocrine signaling at a later stage [41] . Therefore, it is tempting to speculate that pretreatment of IFN-I and FL during pDC expansion induces the production of TGFβ or IL-10 which, in turn, attenuates IFN-I production from pDCs in response to CpG or viral infections. In sum, we have defined several methods to efficiently expand pDCs in vitro and in vivo, which may facilitate the investigation of the developmental process and maybe the functions of pDCs. Moreover, these findings may provide a direction for therapeutic intervention for pDC-associated autoimmune diseases such as systemic lupus erythematosus (SLE) and psoriasis [42] .
Supporting Information S5 Fig. IFN-α4 enhances the proliferation of CLPs in vitro. CLPs (A) and CDPs (B) sorted from WT mice were stimulated with or without FL alone (100 ng/ml) or FL (100 ng/ml) plus IFN-α4 (100 U/ml) for 8 h. BrdU (100 μg/ml) was added at the last 4 h before subjecting the treated cells to intracellular staining for BrdU as described in the Materials and Methods.
